Clinical Trials Start for USask’s COVID-19 Vaccine Candidate

The Vaccine and infectious Disease Organization, a possible home for a Canadian-produced vaccine for COVID-19, is shown at the University of Saskatchewan in Saskatoon, Sask. on February 5, 2021. Kayle Neis/The Canadian Press

HALIFAX—Clinical trials have begun for another Canadian-made COVID-19 vaccine candidate, with three people receiving an initial dose on Wednesday.

The Canadian Center for Vaccinology says the first of 108 healthy adult volunteers received injections in Halifax. The placebo-controlled study will administer two doses to each volunteer, 28 days apart.